TRAVERE THERAPEUTICS, INC. Payments for (Proceeds from) Other Investing Activities
TRAVERE THERAPEUTICS, INC. (TVTX) reported Payments for (Proceeds from) Other Investing Activities of $0 for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsForProceedsFromOtherInvestingActivities · last filed 2026-08-04
- TRAVERE THERAPEUTICS, INC. payments for (proceeds from) other investing activities for the quarter ending 2026-06-30 was $0.00, a 100.00% decline year-over-year.
- TRAVERE THERAPEUTICS, INC. payments for (proceeds from) other investing activities for the quarter ending 2026-03-31 was $0.00, a 100.00% decline year-over-year.
- TRAVERE THERAPEUTICS, INC. payments for (proceeds from) other investing activities for the quarter ending 2025-12-31 was $470.00K, a 1075.00% increase year-over-year.
- TRAVERE THERAPEUTICS, INC. payments for (proceeds from) other investing activities for the quarter ending 2025-09-30 was -$238.00K.
- TRAVERE THERAPEUTICS, INC. payments for (proceeds from) other investing activities for fiscal 2025 was $404.00K, a 910.00% increase from fiscal 2024.
- TRAVERE THERAPEUTICS, INC. payments for (proceeds from) other investing activities for fiscal 2024 was $40.00K, a 94.01% decline from fiscal 2023.
- TRAVERE THERAPEUTICS, INC. payments for (proceeds from) other investing activities for fiscal 2023 was $668.00K, a 15.55% decline from fiscal 2022.
- TRAVERE THERAPEUTICS, INC. payments for (proceeds from) other investing activities for fiscal 2022 was $791.00K.
| Period end | Payments for (Proceeds from) Other Investing Activities 3 month | Payments for (Proceeds from) Other Investing Activities 6 month | Payments for (Proceeds from) Other Investing Activities 6 month as first filed | Payments for (Proceeds from) Other Investing Activities 9 month | Payments for (Proceeds from) Other Investing Activities 12 month | Payments for (Proceeds from) Other Investing Activities 12 month as first filed |
|---|---|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $0.00 10-Q · filed 2026-08-04 | $470.00K derived: sum of 3 quarters · filed 2026-08-04 | $232.00K derived: sum of 4 quarters · filed 2026-08-04 | ||
| 2026-03-31 | $0.00 10-Q · filed 2026-05-04 | $470.00K derived: sum of 2 quarters · filed 2026-05-04 | $232.00K derived: sum of 3 quarters · filed 2026-05-04 | $321.00K derived: sum of 4 quarters · filed 2026-08-04 | ||
| 2025-12-31 | $470.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $232.00K derived: sum of 2 quarters · filed 2026-02-19 | $321.00K derived: sum of 3 quarters · filed 2026-08-04 | $404.00K 10-K · filed 2026-02-19 | ||
| 2025-09-30 | -$238.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | -$149.00K derived: sum of 2 quarters · filed 2026-08-04 | -$66.00K 10-Q · filed 2025-10-30 | -$26.00K derived: sum of 4 quarters · filed 2026-08-04 | ||
| 2025-06-30 | $89.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $172.00K 10-Q · filed 2026-08-04 | -$63.00K 10-Q · filed 2025-08-06 | $212.00K derived: sum of 3 quarters · filed 2026-08-04 | $212.00K derived: sum of 4 quarters · filed 2026-08-04 | |
| 2025-03-31 | $83.00K 10-Q · filed 2026-05-04 | $123.00K derived: sum of 2 quarters · filed 2026-05-04 | $123.00K derived: sum of 3 quarters · filed 2026-05-04 | $123.00K derived: sum of 4 quarters · filed 2026-05-04 | ||
| 2024-12-31 | $40.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $40.00K derived: sum of 2 quarters · filed 2026-02-19 | $40.00K derived: sum of 3 quarters · filed 2026-02-19 | $40.00K 10-K · filed 2026-02-19 | ||
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | $0.00 derived: sum of 2 quarters · filed 2025-10-30 | $0.00 10-Q · filed 2025-10-30 | |||
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $0.00 10-Q · filed 2025-08-06 | ||||
| 2024-03-31 | $0.00 10-Q · filed 2025-05-01 | |||||
| 2023-12-31 | $668.00K 10-K · filed 2026-02-19 | $0.00 10-K · filed 2024-02-20 | ||||
| 2023-06-30 | $633.00K 10-Q · filed 2023-08-03 | |||||
| 2022-12-31 | $791.00K 10-K · filed 2025-02-21 | $600.00K 10-K · filed 2023-02-23 | ||||
| 2022-06-30 | $148.00K 10-Q · filed 2023-08-03 | |||||
| 2021-12-31 | $0.00 10-K · filed 2024-02-20 | |||||
| 2020-12-31 | $0.00 10-K · filed 2023-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Veradermics, Inc (MANE) | United States | $4.839B |